NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling
Journal of Molecular Medicine · 2026
DOI: 10.1007/s00109-026-02730-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Medicine, 2026. Verfasst von Acily Skadon Worral Wilfred Raj und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Guindy Campus, University of Madras, Chennai, 600025, India. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Glucose, Glutamine, Signal Transduction. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Indian Council of Medical Research, KIIC/DST Ignition Grant.
Abstract (Originalsprache)
NUAK1 and NUAK2 are overexpressed in colorectal cancer, and their elevated expression is associated with metastasis and poor patient survival. NUAK1 and NUAK2 promote CRC cell proliferation and migration through metabolic reprogramming, including aerobic glycolysis, the pentose phosphate pathway, and glutamine metabolism. NUAK1 and NUAK2 drive mTOR-mediated metabolic reprogramming and tumor progression by repressing AMPK activity in CRC cells. Targeting NUAK1 and NUAK2 represents a promising therapeutic strategy for colorectal cancer. Colorectal cancer (CRC) cells undergo significant alterations in glucose and glutamine metabolism to support rapid growth and migration. However, the molecular mechanisms underlying these metabolic changes remain incompletely understood. Although NUAK1 and NUAK2, members of the NUAK kinase family have been implicated in CRC tumorigenesis, their specific roles in metabolic reprogramming that drives CRC progression and metastasis have not been elucidated. In this study, we demonstrate that NUAK1 and NUAK2 are overexpressed in human CRC tissues and that their expression is associated with increased tumor metastasis and poorer patient survival. NUAK1/2 promotes CRC cell proliferation and migration, whereas their depletion markedly reduces cell growth and migratory capacity. Furthermore, knockout of NUAK1/2 disrupts key metabolic pathways, including aerobic glycolysis, pentose phosphate pathway (PPP), and glutamine metabolism. Mechanistically, NUAK1/2 facilitates mTOR-driven metabolic reprogramming and promotes CRC growth and migration by suppressing AMPK activity. Depletion of NUAK1/2 impairs metabolic function, cellular growth, and migration potential in CRC cells, effects that are further enhanced by pharmacological activation of AMPK with AICAR and inhibition of mTOR using Rapamycin. In conclusion, these findings identify NUAK1/2 as critical regulators of CRC progression and migration through AMPK/mTOR-mediated metabolic reprogramming, highlighting their potential as therapeutic targets in colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Guindy Campus, University of Madras, Chennai, 600025, India.
- Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641021, India.
- Centre for Cancer Research, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641021, India.
- Department of Biochemistry, Guindy Campus, University of Madras, Chennai, 600025, India. ravimano2004@gmail.com.
Förderung
- Indian Council of Medical Research
- KIIC/DST Ignition Grant
Zitieren
APA
Raj, A. S. W. W., Babu, J. Y. M., Sabanayagam, R., Muthusami, S., & Manoharan, R. (2026). NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-026-02730-5
Vancouver
Raj ASWW, Babu JYM, Sabanayagam R, Muthusami S, Manoharan R. NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling. Journal of Molecular Medicine. 2026. doi:10.1007/s00109-026-02730-5
BibTeX
@article{Raj2026,
author = {Raj, Acily Skadon Worral Wilfred and Babu, Jaithanya Yesupogu Moorthy and Sabanayagam, Rajalakshmi and Muthusami, Sridhar and Manoharan, Ravi},
title = {NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling},
journal = {Journal of Molecular Medicine},
year = {2026},
doi = {10.1007/s00109-026-02730-5}
}
EUVIMED